Clinical trials
Recruiting Cardiovascular Diseases trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2014 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Pontificia Universidad Catolica de Chile | 1 |
| Population Health Research Institute | 1 |
| University of Chile | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 7 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertension | 2 |
| Acute Coronary Syndrome | 1 |
| Aneurysm | 1 |
| Arteriovenous Malformations | 1 |
| Atherosclerosis | 1 |
| Cardiovascular Abnormalities | 1 |
| Communicable Diseases | 1 |
| Congenital Abnormalities | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.